This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 05/01/2023
Location: Virtual
Subject: Center for Medicare and Medicaid Services Quality Conference, Building Resilient Communities: Having an Equitable Foundation for Quality Health Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other registered guests

Event Date: 05/03/2023
Location: Virtual
Subject: Targeting Health Longevity 2023
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 05/03/2023
Location: Virtual
Subject: 17th Annual BioPharma and Healthcare Summit
FDA Participant/Group: DAYLE CRISTINZIO;
Non FDA Participant/Group: Industry, academia, and other registered guests

Event Date: 05/04/2023
Location: Virtual
Subject: Conversations on Cancer - Cancer Misinformation: Truth or Consequences
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered guests

Event Date: 05/05/2023
Location: Virtual
Subject: FDA's Work on Nutrition
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several stakeholders from food industry

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 05/03/2023
Location: Haverford, PA
Subject: Life Sciences Pennsylvania Annual Dinner
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 05/04/2023
Location: Virtual
Subject: Substandard and Falsified Medical Products
FDA Participant/Group: RAVI BHARWANI, ANNA FERUS, DOUG SHAFFER, CHALAL HARINDER
Non FDA Participant/Group: Charles Preston, Ian Hudson (Gates Foundation);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 05/04/2023
Location: Winchester, MA
Subject: Winchester Engineering and Applications Center Ribbon Cutting Ceremony
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stakeholders from industry, government, and other sectors

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/03/2023
Location: Philadelphia, PA
Subject: Rare Drug Development Symposium 2023: How Can the FDA Improve Processes for Rare Diseases?
FDA Participant/Group: N/A
Non FDA Participant/Group: Patient advocates, healthcare, research, and industry stakeholders

Event Date: 05/04/2023
Location: Virtual
Subject: CDC/Infectious Diseases Society of America Clinician Call: FDA Update on Authorization Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other stakeholders

Event Date: 05/05/2023
Location: Washington, DC
Subject: National Organization for Rare Disorders Corporate Council Meeting: Realizing the Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Organization for Rare Disorders Corporate Council

Event Date: 05/06/2023
Location: Washington, DC
Subject: National Organization for Rare Disorders Patient and Family Forum; Panelist: Rare Disease Gene Therapy Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Patient, caregiver, advocate, and healthcare stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 05/01/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from Guidehouse Inc.

Event Date: 05/04/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Jennifer Potts (DLH Holdings Company / Social and Scientific Systems, Inc);

Event Date: 05/04/2023
Location: Virtual
Subject: Update on Activities and Priorities of the Center for Tobacco Products
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from U.S. Senate Committee on Homeland Security and Governmental Affairs

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event